- Home
- ALVR vs PMVP Comparison
ALVR vs PMVP Comparison
Compare ALVR & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALVR
- PMVP
- Stock Information
- Founded
- ALVR 2013
- PMVP 2013
- Country
- ALVR United States
- PMVP United States
- Employees
- ALVR N/A
- PMVP N/A
- Industry
- ALVR Biotechnology: Biological Products (No Diagnostic Substances)
- PMVP Medicinal Chemicals and Botanical Products
- Sector
- ALVR Health Care
- PMVP Health Care
- Exchange
- ALVR Nasdaq
- PMVP Nasdaq
- Market Cap
- ALVR 87.7M
- PMVP 85.5M
- IPO Year
- ALVR 2020
- PMVP 2020
- Fundamental
- Price
- ALVR $0.94
- PMVP $1.65
- Analyst Decision
- ALVR Sell
- PMVP Strong Buy
- Analyst Count
- ALVR 5
- PMVP 4
- Target Price
- ALVR $1.00
- PMVP $5.75
- AVG Volume (30 Days)
- ALVR 155.6K
- PMVP 185.0K
- Earning Date
- ALVR 11-04-2024
- PMVP 11-07-2024
- Dividend Yield
- ALVR N/A
- PMVP N/A
- EPS Growth
- ALVR N/A
- PMVP N/A
- EPS
- ALVR N/A
- PMVP N/A
- Revenue
- ALVR N/A
- PMVP N/A
- Revenue This Year
- ALVR N/A
- PMVP N/A
- Revenue Next Year
- ALVR N/A
- PMVP N/A
- P/E Ratio
- ALVR N/A
- PMVP N/A
- Revenue Growth
- ALVR N/A
- PMVP N/A
- 52 Week Low
- ALVR $0.58
- PMVP $1.33
- 52 Week High
- ALVR $2.49
- PMVP $3.47
- Technical
- Relative Strength Index (RSI)
- ALVR 69.10
- PMVP 60.86
- Support Level
- ALVR $0.74
- PMVP $1.63
- Resistance Level
- ALVR $0.91
- PMVP $1.69
- Average True Range (ATR)
- ALVR 0.06
- PMVP 0.07
- MACD
- ALVR 0.01
- PMVP 0.01
- Stochastic Oscillator
- ALVR 94.50
- PMVP 52.65
About ALVR AlloVir Inc.
AlloVir Inc is a late clinical-stage cell therapy company. The company focuses on developing innovative allogeneic T-cell therapies to combat viral diseases. Their proprietary VST therapy platform enables the creation of off-the-shelf VSTs, addressing the urgent medical need for treating patients with limited viral disease treatment options. With a singular focus on research, development, and commercialization, the company's platform targets 11 devastating viruses, with posoleucel being the lead candidate addressing six viruses. Operating within one segment, the company is dedicated to preventing and treating severe viral-associated diseases through off-the-shelf VST therapies.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.